Scarfe, A. and Wolf, S. (2019): Human dermal allograft for massive rotator cuff tears. Decision Support Document 117.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
The rotator cuff is comprised of several muscles, with tendons that stabilise the shoulder. Post-operative re-tear rates after primary surgical repair of rotator cuff tears range from 20.0-90.0%. The use of a human dermal allograft is intended for patients with a high likelihood of poor healing after repair surgery. In this report, we analysed whether human dermal allograft is more effective and safer than repair surgeries without augmentation.
One randomised controlled trial, two non-randomised controlled trials and seven single arm studies were identified. Overall, the quality of evidence for the effectiveness and safety outcomes was rated as "moderate".
At present, the evidence is insufficient to prove the technology is significantly more effective and safer than the comparator. Thus, we do not recommend the inclusion of the procedure in the Austrian hospital benefit catalogue. A re-evaluation is recommended for 2021.
|Item Type:||Decision Support Document|
|Keywords:||Human dermal allograft, rotator cuff tears, irreparable, GraftJacket, Arthrex|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
W Health professions > W 100-275 Medical, dental and pharmaceutical service plans
QT Physiology > QT 250-275 Leisure Activities. Sports Medicine > QT 261 Sports medicine
WE Musculoskeletal system > WE 168-190 Orthopedics
WO Surgery > WO 660-690 Transplantation
|Series Name:||Decision Support Document 117|
|Deposited on:||15 Jul 2019 08:41|
|Last Modified:||15 Jul 2019 08:41|
Repository Staff Only: item control page